Target intelligence / Profile preview

Multiple luminal substances

Molecular classification
Other
01

Overview

The term Multiple luminal substances does not refer to a single molecular target, such as a specific receptor or enzyme, but rather describes a broad category of diverse molecules found within the lumen of biological cavities, most commonly the gastrointestinal tract. In a pharmacological context, this designation is often used for drugs that act physically or chemically within the lumen to bind, sequester, or neutralize various substances like phosphate, bile acids, dietary fats, or toxins. For example, phosphate binders like sevelamer and bile acid sequestrants like colesevelam interact with these luminal contents to prevent their systemic absorption. Because it encompasses a heterogeneous group of ions, lipids, and metabolic byproducts rather than a defined protein structure, it is considered an imprecise or aggregate target descriptor in therapeutic databases. Consequently, while these substances are the focus of therapeutic intervention, they do not fit the classical definition of a biological drug target.

Other names
Luminal contentsIntestinal luminal substances
02

Mechanism of action

Binding, sequestration, or chemical modification of various substances within the lumen of the gastrointestinal tract or other tubular organs to prevent their absorption or promote their excretion.

03

Biological functions

DigestionAbsorptionExcretionMetabolism
04

Disease associations

HyperphosphatemiaHypercholesterolemiaConstipationDiarrhea
05

Safety considerations

Malabsorption of fat-soluble vitaminsDrug-drug interactions due to non-specific bindingGastrointestinal distress
06

Interacting drugs

Sevelamer

3 more in the full profile.

Beyond the preview

Go deeper on Multiple luminal substances.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple luminal substances.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call